Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-31.09%
0%
-31.09%
6 Months
-28.9%
0%
-28.9%
1 Year
-24.31%
0%
-24.31%
2 Years
-60.26%
0%
-60.26%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
ADICON Holdings Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
4.17
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.97
Tax Ratio
31.98%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
25.61%
ROE (avg)
11.17%
Valuation key factors
Factor
Value
P/E Ratio
74
Industry P/E
Price to Book Value
2.98
EV to EBIT
40.99
EV to EBITDA
16.40
EV to Capital Employed
2.98
EV to Sales
1.65
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.27%
ROE (Latest)
4.03%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
Bearish
Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
3,644.10
5,652.30
-35.53%
Operating Profit (PBDIT) excl Other Income
775.50
1,137.60
-31.83%
Interest
95.40
91.20
4.61%
Exceptional Items
-67.10
114.60
-158.55%
Consolidate Net Profit
289.90
796.40
-63.60%
Operating Profit Margin (Excl OI)
162.10%
161.50%
0.06%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is -35.53% vs 38.77% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is -63.60% vs 105.05% in Dec 2022
About ADICON Holdings Ltd. 
ADICON Holdings Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






